Figure 1 | Scientific Reports

Figure 1

From: Quantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy

Figure 1

Comparative analysis of the antibody responses among the viremic patients (n = 38), ECs (n = 19) and patients with long-term suppressive ART (n = 19) against capsid (p24), protease, reverse transcriptase, integrase, Tat and gp41. Data indicates a lower response in the long-term suppressive ART group against p24, protease, reverse transcriptase and gp41 compared to the other two groups (Mann Whitney U test; p < 0.05 for all analysis).

Back to article page